Mycophenolic Acid: all 424 studies that test it
Page 3 of 5. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.
- Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg CellsStatus unknownNCT05129410Phase 4
- Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus NephritisWithdrawnNCT05101447Phase 2
- Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted GraftActive, not recruitingNCT05088356Phase 1
- Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus ErythematosusStatus unknownNCT05057481Phase 3
- A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap SyndromeStatus unknownNCT04933292Phase 4
- Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)Active, not recruitingNCT04927390Phase 2
- Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe HemoglobinopathiesWithdrawnNCT04776850Early Phase 1
- A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological MalignanciesActive, not recruitingNCT04547049Phase 3
- Randomized Trial Evaluating Mycophenolate Mofetil in Children With Nephrotic Syndrome After Rituximab TreatmentWithdrawnNCT04531865Phase 3
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerWithdrawnNCT04521946Phase 1
- Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event RiskWithdrawnNCT04473924Phase 2
- Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive RegimenStatus unknownNCT04444843Phase 4
- Multitarget Therapy for Idiopathic Membranous NephropathyCompletedNCT04424862Phase 4
- Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaActive, not recruitingNCT04262843Phase 2
- Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity EffectsActive, not recruitingNCT04207177Phase 4
- Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate MofetilCompletedNCT04039373Phase 1
- Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal TransplantationCompletedNCT03968588Phase 4
- Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus NephritisTerminatedNCT03920059Phase 4
- Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft OutcomeCompletedNCT03794492Phase 4
- An Investigational Study of Experimental Medication BMS-986165 in Healthy ParticipantsCompletedNCT03660436Phase 1
- Cyclophosphamide Versus Mycophenolate Mofetil in Lupus NephritisCompletedNCT03200002Phase 2
- Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia MajorStatus unknownNCT03171831Phase 4
- Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous NephropathyStatus unknownNCT03170323Phase 4
- Newly Diagnosed Immune Thrombocytopenia Testing the Standard Steroid Treatment Against Combined Steroid & MycophenolateCompletedNCT03156452Phase 3
- A Drug Interaction Study Between Danicopan and Midazolam, Fexofenadine, and Mycophenolate Mofetil in Healthy ParticipantsCompletedNCT03108274Phase 1
- Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's ArteritisCompletedNCT03096275Phase 3
- A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing ToxicityCompletedNCT03032783Phase 2
- Study to Compare the Pharmacokinetics of Mycophenolate Mofetil Metabolites From Four Tablet Formulations in Healthy ParticipantsCompletedNCT02981290Phase 1
- Efficacy and Safety of a Combination of Mycophenolate Mofetil and Corticosteroid in Advanced IgA NephropathyStatus unknownNCT02981212Phase 4
- Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus NephritisCompletedNCT02949349Phase 2
- Mycophenolate Mofetil Versus Azathioprine in Treatment Naive Autoimmune HepatitisStatus unknownNCT02900443Phase 4
- Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung DiseaseCompletedNCT02896205Phase 3
- Omental Islet TransplantCompletedNCT02821026Phase 1/2
- Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese PatientsStatus unknownNCT02809079Phase 4
- Identification of Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil in Healthy AdultsCompletedNCT02743247Phase 1
- Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCTTerminatedNCT02728700Phase 1
- Allogeneic Stem Cell Transplantation for Children With CMLCompletedNCT02707393Phase 2/3
- Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)WithdrawnNCT02702960Phase 2
- Efficacy and Safety of Mycophenolate Mofetil in subjectswithSjogren's SyndromeStatus unknownNCT02691949Phase 2
- Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell DiseaseTerminatedNCT02678143Phase 1
- Conversion to Sirolimus: Effects in Cytomegalovirus Infection RecurrenceStatus unknownNCT02671318Phase 4
- Allo HSCT Using RIC for Hematological DiseasesCompletedNCT02661035Phase 2
- A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid TumorsTerminatedNCT02653196Early Phase 1
- Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune ThrombocytopeniaWithdrawnNCT02649504Phase 3
- Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMDWithdrawnNCT02563782Phase 2
- A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant ParticipantsCompletedNCT02554955Phase 4
- Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell LymphomaWithdrawnNCT02548468Phase 1
- Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal TransplantationCompletedNCT02540395Not applicable
- The Research of Standard Diagnosis and Treatment for HSPN in ChildrenStatus unknownNCT02532777Phase 2
- Interest of Mycophenolate for CIDP WeaningCompletedNCT02494505Phase 3
- Allo-HSCT With Alternative Donor in Treatment of Hematologic MalignancyCompletedNCT02487069Not applicable
- Study of Treatment Response on IgG4 Related Disease (IgG4RD)Status unknownNCT02458196Phase 2
- Allogeneic Stem Cell Transplantation for Patients With Multiple MyelomaWithdrawnNCT02447055Early Phase 1
- Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental StressStatus unknownNCT02432339Phase 1/2
- Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal FunctionCompletedNCT02334488Phase 3
- Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve GastrectomyCompletedNCT02221583Phase 4
- Intra-Osseous Co-Transplant of UCB and hMSCCompletedNCT02181478Early Phase 1
- Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCeptStatus unknownNCT02095418Not applicable
- TO Compare the Triple Drug Therapy and Dual Therapy .Status unknownNCT02075242Phase 4
- Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level MonitoringWithdrawnNCT02058875Phase 4
- Imatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in ChildrenTerminatedNCT01898377Phase 2
- Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic SyndromeCompletedNCT01895894Phase 4
- Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial FibrosisCompletedNCT01860183Phase 4
- The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy PatientsCompletedNCT01854814Not applicable
- Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant PatientsCompletedNCT01842269Phase 4
- A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)CompletedNCT01822483Phase 4
- Myfortic in High MELD Liver TransplantationWithdrawnNCT01807767Not applicable
- A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant RecipientsCompletedNCT01780844Phase 2
- The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)Status unknownNCT01766518Phase 4
- the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia PatientStatus unknownNCT01766375Phase 3
- A Study to Assess the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Mycophenolate Mofetil in Healthy Adult SubjectsCompletedNCT01711489Phase 1
- Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis CongenitaActive, not recruitingNCT01659606Phase 2
- Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)CompletedNCT01595984Phase 3
- Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy DeteriorationStatus unknownNCT01566006Not applicable
- Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fed ConditionsCompletedNCT01513057Phase 1
- Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule, Under Fasting ConditionsCompletedNCT01513044Phase 1
- Clonal Deletion on Living-Relative Donor Kidney TransplantationStatus unknownNCT01408797Phase 1/2
- Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Mycophenolate Mofetil in Healthy VolunteersCompletedNCT01364987Phase 1
- Clinical Trial Treatment in Lupus NephritisWithdrawnNCT01299922Phase 3
- Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Non-Fasting ConditionsCompletedNCT01283867Phase 1
- Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Fasting ConditionsCompletedNCT01283841Phase 1
- An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)CompletedNCT01269021Not applicable
- Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant RecipientsTerminatedNCT01213394Phase 3
- Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic SyndromeCompletedNCT01197040Phase 3
- Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized StudyCompletedNCT01185197Phase 4
- Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic MalignanciesCompletedNCT01175785Phase 2
- Attenuating Ischemia Reperfusion Injury After Living Donor Renal TransplantationWithdrawnNCT01149993Phase 4
- Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]Status unknownNCT01109498Phase 2/3
- Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE)CompletedNCT01101802Phase 4
- Cyclophosphamide Versus Mycophenolate Mofetil for the Treatment of Steroid-dependent Nephrotic Syndrome in ChildrenCompletedNCT01092962Phase 3
- Myfortic for the Treatment of Non-infectious Intermediate UveitisCompletedNCT01092533Phase 3
- Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fasting ConditionCompletedNCT01080443Not applicable
- Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed ConditionCompletedNCT01080417Not applicable
- Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus NephritisCompletedNCT01056237Not applicable
- Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus NephritisCompletedNCT01042457Phase 3
- Comparison of Tacrolimus and Myfortic Versus Tacrolimus and SirolimusWithdrawnNCT01038505Phase 4
- The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus NephritisTerminatedNCT01015456Phase 3
- Study of CellCept for Advanced Pancreatic CancerCompletedNCT00997958Phase 1
- Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia GravisStatus unknownNCT00997412Not applicable
- Bayesian Dose Adjustment of Immunosuppressants After Lung TransplantationTerminatedNCT00975663Phase 4